BT (NYSE: BT) has concluded its delayed trial of the controversial behavioural ad targeter Phorm and hopes to roll out the service to its ISP customers. Phorm told the market this morning: “The trial achieved its primary objective of testing all the elements necessary for a larger deployment, including the serving of small volumes of targeted advertising. There will now be a period of joint analysis of the results. Following the successful completion of analysis, both of the trial results and of any changes required for expansion, BT has informed the company that it expects to move towards deployment.”

SEE ALSO: BT’s Phorm Trial Starting Tomorrow

BT still hasn’t made any public announcement as such; its site for BT Webwise, the name under which the technology has been tested, still says: “After assessing the findings, we will make further announcements on this website concerning the launch of the service for BT Total Broadband customers.”